End stage renal disease requiring renal replacement therapy Urological and Genital Diseases End-stage renal disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 80 2. Presence of end stage renal disease (ESRD) 3. Initiation of Continuous Ambulatory Peritoneal Dialysis (CAPD) therapy in our hospital 4. Expected survival greater than 6 months 5. Provision of informed consent to participate in the study
Exclusion criteria
Exclusion criteria: 1. Unstable or poorly controlled coronary artery disease 2. Severe congestive heart failure (New York Heart Association Grade III or IV) 3. Severe chronic respiratory disease, malignant disease, clinically significant hepatic disease, acute renal failure and psychiatric disease 4. Women who were pregnant or lactating
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Catheter tip migration defined as catheter tip located above the pelvic brim on the abdominal X-ray with associated catheter dysfunction | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. All-cause catheter failure (defined by a necessity to remove or reposition the catheter by surgical methods) 2. Catheter related infections (including peritonitis, exit-site infection and tunnel infection) 3. Technique survival (defined as time to permanent transition to haemodialysis) and overall patient survival | — |
Countries
China